Plain-English translation of NCT06153082 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether one of two blood clotting tests — called ROTEM or TEG — can better guide doctors in giving you the right blood products when you're bleeding from liver cirrhosis. Both tests measure how well your blood clots, but they work slightly differently. The goal is to find which test helps doctors use blood transfusions more safely and effectively.
People with cirrhosis often have problems with blood clotting and may need transfusions when they bleed. However, doctors don't always agree on the best way to decide which blood products patients need. This trial will help determine if one of these clotting tests is better at guiding transfusion decisions, potentially reducing unnecessary transfusions and improving patient outcomes.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive care guided by either the ROTEM or TEG blood clotting test. Your doctors will perform the test you're assigned to and use the results to decide which blood products (like plasma, platelets, or fibrinogen) you need during your treatment for bleeding. The study will track your blood transfusions, bleeding control, and any side effects over the course of your hospitalization and recovery.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
India